|
Real-time Estimate
Cboe Europe
12:59:59 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,867.50 GBX | +0.76% |
|
-1.32% | +2.25% |
| 12:51pm | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 12:07pm | GSK to launch a Phase III trial for an mRNA vaccine candidate |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.76% | -1.32% | -3.42% | +1.25% | +2.25% | +28.88% | +34.32% | +2.08% | -8.94% | 101B | |
| -1.52% | -7.23% | +0.69% | +4.68% | +7.63% | +57.90% | +108.72% | +347.84% | +1,387.76% | 1,031B | |
| -0.82% | -2.63% | +3.71% | +17.98% | +28.46% | +50.05% | +64.43% | +53.56% | +122.77% | 641B | |
| +0.37% | -3.06% | +2.18% | +17.78% | +12.22% | +21.87% | +74.48% | +112.30% | +300.03% | 453B | |
| -1.66% | -6.29% | -1.84% | +9.36% | +5.76% | +33.40% | +33.35% | -5.62% | +44.75% | 349B | |
| +4.87% | +2.11% | +2.24% | +13.64% | +18.10% | +27.48% | +44.93% | +52.66% | +67.24% | 290B | |
| +0.14% | -0.78% | -4.88% | -10.56% | -12.86% | +1.40% | +12.70% | +41.13% | +144.77% | 252B | |
| -0.59% | -3.15% | +11.61% | +30.61% | +31.34% | +49.83% | +67.70% | +90.61% | +152.78% | 232B | |
| +0.21% | -2.04% | -4.36% | +2.90% | -9.87% | -19.71% | -53.98% | -6.60% | +87.50% | 201B | |
| +0.45% | -0.27% | +12.39% | +11.62% | +19.23% | +29.84% | +91.34% | +101.07% | +86.71% | 181B | |
| +1.79% | +1.75% | +13.79% | +8.71% | +14.30% | +14.94% | -19.56% | -38.22% | -18.22% | 162B | |
| +0.52% | -0.56% | +14.13% | +24.21% | +20.11% | +35.79% | +56.32% | +171.87% | +476.15% | 138B | |
| +0.35% | -0.70% | +2.30% | +16.84% | +23.86% | +41.61% | +8.37% | -0.07% | +16.41% | 136B | |
| +0.66% | -1.80% | +3.79% | +4.26% | -6.53% | -8.70% | -21.59% | -12.27% | +13.09% | 107B | |
| +0.30% | -0.76% | +0.03% | -9.53% | -15.88% | +6.35% | +55.58% | +60.96% | +541.05% | 71.2B | |
| +1.39% | +0.83% | +6.02% | +19.75% | +20.89% | +30.79% | +29.66% | +58.87% | +28.18% | 57.62B | |
| +0.09% | +1.46% | +2.37% | +40.02% | +32.91% | +76.56% | -2.67% | +4.34% | -48.74% | 55.96B | |
| -2.64% | -3.50% | -15.70% | -8.21% | -22.66% | -30.44% | +9.30% | +1.03% | +187.21% | 45.1B | |
| +0.46% | -0.03% | +1.76% | +13.13% | -1.36% | +2.50% | +14.64% | - | - | 43.95B | |
| -1.07% | -2.38% | +2.97% | +2.07% | +15.51% | +96.14% | +269.36% | +282.70% | -28.46% | 42.01B | |
| Average | +0.31% | -1.69% | +2.49% | +10.53% | +9.17% | +27.32% | +43.87% | +69.38% | +186.95% | 229.49B | |
| Weighted average by Cap. | +0.52% | -3.26% | +2.50% | +10.76% | +11.72% | +34.64% | +56.91% | +119.20% | +417.07% |
- Stock Market
- Stocks
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
